Static Chart SELLAS Life Sciences Group, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 03:29:50 2024-05-15 pm EDT			5-day change	1st Jan Change
1.455 ^USD	+6.20%		+13.67%	+37.26%

May. 01	SELLAS Life Sciences Group, Inc. Announces Positive Phase 2 Preliminary Data of SLS009 in r/r AML Achieving a 100% Response Rate in Patients with ASXL1 Mutation At the Optimal Dose Level	CI
Apr. 29	SELLAS Life Sciences Group, Inc. Announces Positive Recommendation of Independent Data Monitoring Committee Following Completion of Enrollment in REGAL Phase 3 Study	CI

Duration

Period